National Drug Control Strategy and Its Impact on Addiction Treatment
Explore the National Drug Control Strategy's impact on addiction treatment, Medicaid cuts, and overdose prevention efforts amid funding challenges and policy shifts.
Explore the National Drug Control Strategy's impact on addiction treatment, Medicaid cuts, and overdose prevention efforts amid funding challenges and policy shifts.
Illinois nursing facilities reach $300K settlement over false Medicare claims, emphasizing the significance of compliance and patient-centered care.
Join us for a pivotal CBO presentation on Medicare Part D's impacts on health financing reforms. Insights on policy changes and budget strategies await.
RAAPID INC's new Risk Adjustment Platform enhances compliance and coding accuracy for Medicare Advantage, addressing fiscal and regulatory challenges effectively.
Foley & Lardner boosts its Nashville office with Shannon Kukulka, enhancing employee benefits expertise across healthcare and insurance sectors. Read more!
Explore the potential $529 billion savings from the MFN drug pricing proposal, while emphasizing the need for transparency in pharmaceutical agreements and regulatory compliance.
Explore how rising U.S. annuity sales reshaped financial metrics and risk profiles of life insurers, with insights from AM Best's report.
Discover how Willis's Merger Protect insurance minimizes risks and costs during M&A regulatory reviews, ensuring smoother transactions for organizations.
Explore how 43 states will implement Medicaid work requirements by 2027, adapting to federal guidance and evaluating hardship exemptions to ensure compliance.
Explore how property and casualty insurers can effectively navigate compliance challenges in creator-led marketing while enhancing engagement and maintaining legal standards.